Lepu medical: Wei Zhanjiang, deputy general manager, increased 113600 shares

IntoCare Zhang Hui: Ingenuity Forges Quality, Continuous Improvement Safeguards Lives

In 2024, nearly all medical enterprises are exploring overseas markets. This trend is driven by an anti-corruption wave within the medical industry, the demand for financing and initial public offerings, as well as challenges such as excess production capacity. Presently, venturing abroad has become an essential developmental path for medical device enterprises. Successfully entering foreign markets is not only a crucial means for the medical industry to achieve a second grow

Doubt Cast on Singapore’s Effort to Preserve Hawker Culture

A new initiative allowing certain foreigners to work as food stall assistants in Singapore’s hawker trade may face challenges in attracting applicants due to the physically demanding nature of the job and its relatively low wages, policy experts suggest.

Argentina's wave of SME closures continues, with a bleak recovery outlook

Top 10 Market Cap Chinese Medical Device Companies: Champions and Runners-Up

In a recent boom in the Chinese A-share market, the medical device segment has shown a surprising performance, proving its investability and growth potential.

USD 130 Million Series A Financing Fuels Lepu Biotech

Lepu Biotech announced Series A financing of CNY 900 million. Shiyu Capital took the lead in this round. Lepu Biotech has several pipelines for precision treatment and targeted therapy for solid tumors.